JP2023509966A5 - - Google Patents
Info
- Publication number
- JP2023509966A5 JP2023509966A5 JP2022542209A JP2022542209A JP2023509966A5 JP 2023509966 A5 JP2023509966 A5 JP 2023509966A5 JP 2022542209 A JP2022542209 A JP 2022542209A JP 2022542209 A JP2022542209 A JP 2022542209A JP 2023509966 A5 JP2023509966 A5 JP 2023509966A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- composition according
- dna sequence
- dna
- promoter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062959435P | 2020-01-10 | 2020-01-10 | |
| US62/959,435 | 2020-01-10 | ||
| PCT/US2021/012834 WO2021142366A1 (en) | 2020-01-10 | 2021-01-08 | Compositions and methods of use of oncolytic virus like vesicles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023509966A JP2023509966A (ja) | 2023-03-10 |
| JP2023509966A5 true JP2023509966A5 (cg-RX-API-DMAC7.html) | 2024-01-15 |
Family
ID=74595378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022542209A Pending JP2023509966A (ja) | 2020-01-10 | 2021-01-08 | 腫瘍溶解性ウイルス様小胞の組成物および使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12577585B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4087858A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023509966A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115397838A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021142366A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025504364A (ja) * | 2022-01-08 | 2025-02-12 | カロジェン コーポレイション | 慢性b型肝炎感染症を処置または防止するための複数抗原治療ワクチン |
| JP2025508866A (ja) * | 2022-02-22 | 2025-04-10 | ヴァイロ バイオ インク. | 腫瘍溶解性ウイルスおよび使用方法 |
| JP2025506732A (ja) * | 2022-02-22 | 2025-03-13 | カロジェン コーポレイション | 感染症およびがんの免疫療法適用のための多用途のウイルス様小胞(vlv)プラットフォーム |
| CN117327709A (zh) * | 2022-06-24 | 2024-01-02 | 深圳瑞吉生物科技有限公司 | 用于实体肿瘤的治疗性mRNA及其应用 |
| US20260034208A1 (en) * | 2022-07-26 | 2026-02-05 | Yale University | Virus-like vesicles (vlvs) based vaccines and methods of preventing, ameliorating, and/or treating covid-19 and/or hepatocellular carcinoma (hcc) |
| IL320318A (en) * | 2022-10-19 | 2025-06-01 | Kalivir Immunotherapeutics Inc | Nucleic acids encoding tgf-beta inhibitor and il-12 and uses thereof |
| WO2024119388A1 (zh) * | 2022-12-07 | 2024-06-13 | 上海鑫湾生物科技有限公司 | 一种用于共表达多种目的基因的构建体及其用途 |
| CN118831091A (zh) * | 2023-04-11 | 2024-10-25 | 浙江自贸区红岸基地生物科技有限公司 | 一种saRNA递送系统及其制备方法和应用 |
| WO2025208054A1 (en) * | 2024-03-28 | 2025-10-02 | Regeneron Pharmaceuticals, Inc. | Recombinant rhabdovirus encoding interleukin-12 (il-12) |
| CN120733012B (zh) * | 2024-08-20 | 2026-08-07 | 浙江大学 | 基于mRNA及蛋白编码的肿瘤药物、制备方法及应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1053751A1 (en) * | 1999-05-17 | 2000-11-22 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Compositions and methods for treating cell proliferation disorders |
| FR2862982B1 (fr) | 2003-12-02 | 2006-04-28 | Genethon | Particules virales contenant un vecteur derive d'alpha-virus et procede de preparation de ladite particule virale. |
| AU2007342333B2 (en) * | 2006-09-12 | 2013-02-28 | Alphavax, Inc. | Alphavirus replicon particles encoding IL- 12 as immunological adjuvants |
| WO2008119827A1 (en) * | 2007-04-02 | 2008-10-09 | Fit Biotech Oy | Transreplicase constructs |
| GB2460265A (en) | 2008-05-23 | 2009-11-25 | Univ Dublin City | Detection assembly |
| AU2015259470A1 (en) * | 2014-05-16 | 2016-11-10 | Yale University | Virus like vesicles (VLVs) based vaccines to prevent or treat chronic hepatitis B virus (HBV) infection |
| WO2015175382A1 (en) | 2014-05-16 | 2015-11-19 | Yale University | Evolution of high-titer virus-like vesicles for vaccine applications |
| EP3437654B1 (en) | 2016-03-31 | 2023-09-20 | Centro De Ingeniería Genética Y Biotecnología | Pharmaceutical composition that includes the surface and nucleocapsid antigens of the hepatitis b virus |
| CN110050062A (zh) * | 2016-08-09 | 2019-07-23 | 阿尔莫哈纳德·阿尔卡亚尔 | 表达il12的溶瘤弹状病毒 |
| PT3684786T (pt) | 2017-09-22 | 2024-10-30 | Centre Nat Rech Scient | Glicoproteína mutante do vírus da estomatite vesicular |
-
2021
- 2021-01-08 US US17/791,873 patent/US12577585B2/en active Active
- 2021-01-08 JP JP2022542209A patent/JP2023509966A/ja active Pending
- 2021-01-08 WO PCT/US2021/012834 patent/WO2021142366A1/en not_active Ceased
- 2021-01-08 EP EP21705306.5A patent/EP4087858A1/en active Pending
- 2021-01-08 CN CN202180020228.5A patent/CN115397838A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gardner et al. | Infection of human dendritic cells by a sindbis virus replicon vector is determined by a single amino acid substitution in the E2 glycoprotein | |
| CA2410948C (en) | Method for the purification of alphavirus replicon particles | |
| JP7855208B2 (ja) | 非組み込みウイルス送達系およびその関連方法 | |
| JP2022191506A5 (cg-RX-API-DMAC7.html) | ||
| CN111358953A (zh) | 一种高效诱导机体体液免疫应答的疫苗载体、其制备方法及用途 | |
| CN106967685B (zh) | 共表达抗EGFRvIII嵌合抗原受体和免疫检查点抑制分子的转基因淋巴细胞及其用途 | |
| JP2023509966A (ja) | 腫瘍溶解性ウイルス様小胞の組成物および使用方法 | |
| JP2023521662A5 (cg-RX-API-DMAC7.html) | ||
| Ljungberg et al. | Increased immunogenicity of a DNA-launched Venezuelan equine encephalitis virus-based replicon DNA vaccine | |
| CN108017717A (zh) | 一种用于体外高效定向扩增的嵌合抗原受体及其应用 | |
| JP2024073653A (ja) | 遺伝子改変リンパ球の製造方法 | |
| CN106459997A (zh) | 用于疫苗应用的高效价病毒样囊泡的进化 | |
| CN110832072A (zh) | 用于生产非复制型腺病毒的细胞系以及制备所述细胞系的方法 | |
| CN118234850A (zh) | 利用微rna来下调经修饰的安卡拉痘苗病毒(mva)的细胞毒性转基因的表达 | |
| US20260069678A1 (en) | Conjugate polypeptides and vaccines for inducing immune responses | |
| Zhang et al. | Virus-like vesicles based on Semliki forest virus-containing rabies virus glycoprotein make a safe and efficacious rabies vaccine candidate in a mouse model | |
| Cervantes-Barragan et al. | Dendritic cell-specific antigen delivery by coronavirus vaccine vectors induces long-lasting protective antiviral and antitumor immunity | |
| Lundstrom | Viral vector-based cancer vaccines | |
| CN109796536B (zh) | 一种靶向胶质母细胞瘤多种抗原表位的ctl的制备方法 | |
| JP2024542126A5 (cg-RX-API-DMAC7.html) | ||
| CN120366237A (zh) | 重组溶瘤疱疹病毒及其应用 | |
| Karlsson et al. | Live viral vectors: Semliki Forest virus | |
| Gea-Mallorquí et al. | DC-targeting lentivectors for cancer immunotherapy | |
| WO2023015276A1 (en) | Adenoviral vector-based vaccine for emerging viruses | |
| Aranda et al. | A quick and efficient method to generate mammalian stable cell lines based on a novel inducible alphavirus DNA/RNA layered system |